Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria.
D&R Institute of Hygiene Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Infection. 2020 Dec;48(6):853-860. doi: 10.1007/s15010-020-01453-0. Epub 2020 May 27.
Microbial dysbiosis has been found preceding necrotizing enterocolitis (NEC) in preterm infants; thus, we aimed to investigate whether there is evidence that neonates with extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) positive stool cultures are at higher risk for NEC at the NICU.
We included very preterm inborn infants of ≤ 32 weeks of gestational age being fecal carriers of ESBL-E and compared them with 1:1 matched (gestational age, birth weight, gender and year) controls tested negative for ESBL-E in the stool between 2005 and 2016. An association with NEC was defined as the first detection of ESBL-E before or at the time of definite diagnosis of NEC.
During the study period, we diagnosed 217 infants with a total of 270 ESBL-E. We identified ten different species with ESBL-producing Klebsiella oxytoca being the most common one (46%) followed by Klebsiella pneumoniae (19%), and Citrobacter freundii (17%). Ten out of 217 infants had any kind of NEC in the case group compared to two of the controls (p < 0.01), but only four cases with predefined criteria were associated with NEC ≥ stage IIa (1.8 vs. 0.5%, p = 0.089, OR 4.1, CI95% 0.45-36.6). NEC mortality rate was 2/8 (25%).
We observed a threefold increase of ESBL-E in stool surveillance cultures during study time and germs were dominated by ESBL-producing Klebsiella spp. There was no evidence that preterm infants colonized with ESBL-E in the stool were at higher risk for definite NEC.
研究发现在早产儿坏死性小肠结肠炎(NEC)发生之前存在微生物失调;因此,我们旨在研究在新生儿重症监护病房(NICU)中,产超广谱β-内酰胺酶肠杆菌科(ESBL-E)阳性粪便培养的新生儿是否有更高的 NEC 风险。
我们纳入了胎龄≤32 周的极早产儿,这些早产儿为 ESBL-E 粪便携带者,并将其与 2005 年至 2016 年间粪便中未检测到 ESBL-E 的 1:1 匹配(胎龄、出生体重、性别和年份)对照进行比较。ESBL-E 的首次检测时间在 NEC 确诊前或同时定义为与 NEC 相关。
在研究期间,我们共诊断出 217 例婴儿,共有 270 例 ESBL-E。我们鉴定出十种不同的产 ESBL 细菌,其中产 ESBL 肺炎克雷伯菌最常见(46%),其次是肺炎克雷伯菌(19%)和弗氏柠檬酸杆菌(17%)。在病例组中,有 10 名婴儿发生任何类型的 NEC,而对照组中只有 2 名(p<0.01),但只有 4 例符合预设标准与 NEC≥Ⅱa 期相关(1.8%与 0.5%,p=0.089,OR 4.1,95%CI 0.45-36.6)。NEC 死亡率为 2/8(25%)。
我们观察到研究期间粪便监测培养中 ESBL-E 的数量增加了三倍,细菌主要为产 ESBL 肺炎克雷伯菌。没有证据表明粪便中定植 ESBL-E 的早产儿发生明确的 NEC 的风险更高。